Prot #1424R2131: A Multicenter, Randomized, Open-label Clinical Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
- Wunderink, Richard G (PD/PI)
Project: Research project